Loading data for TBIO — first visit, this takes a few seconds.
Telesis Bio, Inc. (TBIO)
OTC Markets OTCPK: TBIO
· Real-Time Price · USD
0.00
+0.00 (n/a)
At close: Sep 07, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Telesis Bio, Inc. (TBIO) Stock Price, Analysis & Data
No data available
| Bid | 0.3 |
| Market Cap | 1.77K |
| Revenue (ttm) | 17M |
| Net Income (ttm) | -47.4M |
| 2.47 | |
| -27.65 | |
| n/a | |
| 0 | |
| P/B (ttm) | 0.00 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.4 |
| Volume | 3 |
| Avg. Volume (20D) | 534 |
| Open | 0.01 |
| Previous Close | 0.00 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.00 - 0.15 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TBIO
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard ne...
Industry Medical Devices
Sector Healthcare
IPO Date Jun 18, 2021
Employees 39
Stock Exchange OTC Markets OTCPK
Ticker Symbol TBIO
Website https://telesisbio.com
Financial Performance
In 2023, Telesis Bio's revenue was 27.51M, an increase of 0.27% compared to the previous year's 27.44M. Earnings were -47.72M, a decrease of -1.54%.
Financial StatementsEarnings Surprise
Telesis Bio has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.